@Yosukemino I have included ‘API Raw materials’ as part of the thread title. Thanks for the clarification. I have uploaded the "Health Canada’ Q&A document on Nitrosamine, and It’s quite clear the call to API, Excipients, and ingredients manufacturers to openly assist on the risk assessment. Perhaps good conversation to have with suppliers
I am wondering if any of our API or Excipient manufacturers have a perspective to share with the community. Perhaps what are they doing differently to collaborate? @JavierFernandez @rwalliser @KariA @jakob.bonde @tsammeli @Narayana